The rise of fatty liver disease is an emerging health crisis, resulting in chronic illness for millions of people and escalating healthcare costs. Definitive diagnostic tools for this disease are limited to biopsy and MRI, and are expensive, invasive and time-consuming. To address this crisis, physicians need a better tool to assess and manage disease. Velacur^TM is a point of care solution that measures liver stiffness and attenuation and can aid in the management of patients with liver disease.